PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Phenotype | C0027947|neutropenia |
| Sentences | 7 |
| PubMedID- 21773751 | Identifying risk factors for refractory febrile neutropenia in patients with lung cancer. |
| PubMedID- 24679653 | We assessed the efficacy and safety of cefepime monotherapy (1 g intravenously every 8 h) for febrile neutropenia in patients with lung cancer in a multi-institutional phase ii study. |
| PubMedID- 23489558 | Clinicians should be aware that gefitinib-induced neutropenia in patients with non-small cell lung cancer can be treated successful by switching to erlotinib. |
| PubMedID- 26434104 | Pentraxin-3 as a biomarker for febrile neutropenia in patients with lung cancer. |
| PubMedID- 23173291 | [febrile neutropenia in lung cancer patients]. |
| PubMedID- 23053498 | Elevation of serum c-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer. |
| PubMedID- 21707992 | Methods: we analyzed the medical records of lung cancer patients with neutropenia (neutrophil count < 500/mm(3)) and fever (temperature > 38.3 degrees c). |
Page: 1